Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Jun;141(6):1601-1604.e2.
doi: 10.1016/j.jid.2020.12.009. Epub 2021 Jan 8.

Lack of Systemic Absorption of Topical Mechlorethamine Gel in Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma

Christiane Querfeld  1 , Larisa J Geskin  2 , Ellen J Kim  3 , Julia J Scarisbrick  4 , Pietro Quaglino  5 , Evangelia Papadavid  6 , James T Angello  7 , Pablo L Ortiz-Romero  8
Affiliations
Randomized Controlled Trial

Lack of Systemic Absorption of Topical Mechlorethamine Gel in Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma

Christiane Querfeld et al. J Invest Dermatol. 2021 Jun.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kim YH, Martinez G, Varghese A, Hoppe RT. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience. Arch Dermatol 2003;139:165–73. - PubMed
    1. Kim YH, Duvic M, Guitart J, Lessin S. Efficacy and safety of mechlorethamine (MCH) 0.04% gel in mycosis fungoides (MF) after treatment with topical MCH 0.02%. J Clin Oncol 2014;32:9093 (Abstr).
    1. Ledaga [summary of product characteristics]. 2018. https://www.ema.europa.eu/en/documents/product-information/ledaga-epar-p.... Accessed August 21, 2020.
    1. Lessin SR, Duvic M, Guitart J, Pandya AG, Strober BE, Olsen EA, et al. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides. JAMA Dermatol 2013;149:25–32. - PMC - PubMed
    1. Lindahl LM, Fenger-Grøn M, Iversen L. Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study. Br J Dermatol 2014;170:699–704. - PubMed